Literature DB >> 8896826

Progressive expression of immunomolecules on activated microglia and invading leukocytes following focal cerebral ischemia in the rat.

H Kato1, K Kogure, X H Liu, T Araki, Y Itoyama.   

Abstract

In order to evaluate the involvement of inflammatory reactions following focal cerebral ischemia in the rat, we immunohistochemically visualized microglial cells and blood-borne leukocytes (neutrophils and monocytes) using various antibodies directed against immunomolecules expressed on these cells. Focal cerebral ischemia was produced by intraluminal occlusion of the right middle cerebral artery for 1 h. The brains were perfusion-fixed at 4 h, 1 day, 3 days, 7 days and 14 days after ischemia. Frozen brain sections were prepared and stained with monoclonal antibodies to complement receptor type 3 (OX42), major histocompatibility complex (MHC) class I and class II antigens (OX18 and OX6, respectively), a pan-macrophage/monocyte marker (ED1), intercellular adhesion molecule-1 (ICAM-1), LFA-1 alpha chain (CD11a) and beta chain (CD18), and T cells (CD5). In ischemic areas where infarction developed later, microglial cells were destroyed (beginning at 4 h), neutrophils migrated (1-3 days), and then monocytes/macrophages infiltrated and covered the entire lesions (3-14 days). The invading leukocytes expressed CD11 and CD18 adhesion molecules on their cell surface while ICAM-1 was expressed on endothelial cells. In surrounding areas, in contrast, there was a rapid activation of microglia showing morphological changes and upregulation of OX42 immunoreactivity (4 h-7 days), especially in the transitional rim of the infarct (7 days). ED1 and MHC antigens were expressed on both activated microglia and invading leukocytes. Thus, developing infarction was accompanied by accumulation of inflammatory cells of both intrinsic (microglia) and extrinsic (leukocytes) origins. Thus, results suggest that the relative importance of each source is determined by the time after ischemia and the site within the lesion, and that the expression of immunological molecules plays an important role in eliciting such inflammatory reactions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8896826

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  28 in total

1.  Time dependent changes of striatal interneurons after focal cerebral ischemia in rats.

Authors:  M Sakuma; N Hyakawa; H Kato; T Araki
Journal:  J Neural Transm (Vienna)       Date:  2008-02-26       Impact factor: 3.575

2.  Glial damage after transient focal cerebral ischemia in rats.

Authors:  Shunsuke Matsuda; Masahiro Umeda; Hiroyuki Kato; Tsutomu Araki
Journal:  J Mol Neurosci       Date:  2008-12-03       Impact factor: 3.444

Review 3.  The multifaceted profile of activated microglia.

Authors:  Marina A Lynch
Journal:  Mol Neurobiol       Date:  2009-07-23       Impact factor: 5.590

4.  Expression of CD54 (intercellular adhesion molecule-1) and the beta 1 integrin CD29 is modulated by a cyclic AMP dependent pathway in activated primary rat microglial cell cultures.

Authors:  S H Zuckerman; J Gustin; G F Evans
Journal:  Inflammation       Date:  1998-02       Impact factor: 4.092

Review 5.  Anti-inflammatory role of fetuin-A in injury and infection.

Authors:  H Wang; A E Sama
Journal:  Curr Mol Med       Date:  2012-06       Impact factor: 2.222

6.  Bridging the pharmacokinetics and pharmacodynamics of UK-279,276 across healthy volunteers and stroke patients using a mechanistically based model for target-mediated disposition.

Authors:  E Niclas Jonsson; Fiona Macintyre; Ian James; Michael Krams; Scott Marshall
Journal:  Pharm Res       Date:  2005-08-03       Impact factor: 4.200

7.  The powerful neuroprotective action of C1-inhibitor on brain ischemia-reperfusion injury does not require C1q.

Authors:  Maria Grazia De Simoni; Emanuela Rossi; Claudio Storini; Simone Pizzimenti; Cinara Echart; Luigi Bergamaschini
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

8.  CNS immune responses following experimental stroke.

Authors:  Dannielle Zierath; Matthew Thullbery; Jessica Hadwin; J Michael Gee; Anna Savos; Angela Kalil; Kyra J Becker
Journal:  Neurocrit Care       Date:  2009-08-28       Impact factor: 3.210

9.  Leukocyte recruitment and ischemic brain injury.

Authors:  Gokhan Yilmaz; D Neil Granger
Journal:  Neuromolecular Med       Date:  2009-07-05       Impact factor: 3.843

10.  Role of mechanistically-based pharmacokinetic/pharmacodynamic models in drug development : a case study of a therapeutic protein.

Authors:  Scott Marshall; Fiona Macintyre; Ian James; Michael Krams; Niclas E Jonsson
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.